Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma

被引:0
作者
Dingyuan Hu
Daniel Ansari
Qimin Zhou
Agata Sasor
Katarzyna Said Hilmersson
Roland Andersson
机构
[1] The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University,Department of Gastroenterology
[2] Lund University and Skåne University Hospital,Department of Surgery, Clinical Sciences Lund
[3] Skåne University Hospital,Department of Pathology
来源
World Journal of Surgical Oncology | / 17卷
关键词
Fibronectin; Pancreatic ductal adenocarcinoma; Survival; Immunohistochemistry;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 166 条
[1]  
Siegel RL(2018)Cancer statistics, 2018 CA Cancer J Clin 68 7-30
[2]  
Miller KD(2014)Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States Cancer Res 74 2913-2921
[3]  
Jemal A(2017)Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial Lancet 389 1011-1024
[4]  
Rahib L(2017)Systemic therapy in advanced melanoma: integrating targeted therapy and immunotherapy into clinical practice Curr Opin Oncol 29 484-492
[5]  
Smith BD(2018)Therapeutic developments in pancreatic cancer: current and future perspectives Nat Rev Gastroenterol Hepatol 15 333-348
[6]  
Aizenberg R(1995)Altered expression of extracellular matrix molecules and their receptors in chronic pancreatitis and pancreatic adenocarcinoma in comparison with normal pancreas Int J Pancreatol 18 227-234
[7]  
Rosenzweig AB(2014)Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival Cancer Cell 25 719-734
[8]  
Fleshman JM(2016)Matrix control of pancreatic cancer: new insights into fibronectin signaling Cancer Lett 381 252-258
[9]  
Matrisian LM(2002)Fibronectin at a glance J Cell Sci 115 3861-3863
[10]  
Neoptolemos JP(2007)A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo J Transl Med 5 61-12